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Mitochondrial proteome1. Introduction
Mitochondria are traditionally described in biochemistry textbooks
as the power plants of a cell; although this is true, this limiting descrip-
tion underestimates the far reaching roles of this organelle in a variety
of critical cellular processes unrelated to energy production. Mitochon-
dria are key players in several cellular processes, including respiration,
biosynthesis, apoptosis signalling and ion homeostasis. They are also
generators of reactive oxygen species (ROS) which are themselves
players in different signalling pathways [1,2]. These pathways share
speciﬁc redox reactions [3], in which the mitochondrial oxidative de-
fense system [4] contributes to maintain redox homeostasis.
Mitochondria have been implicated in several diseases, such as
Parkinson's and Alzheimer's [5,6]. Additionally, their involvement in
cancer [7,8], apoptosis signalling [9] and stem cell development [10] is
under extensive research.
Modern techniques enabled the investigation of the internal struc-
ture and morphology of mitochondria and revealed a highly complex
compartmentalisation [11,12]. The organelle is surrounded by a double
membrane. This allows the assignment of the mitochondrial matrix
(MM), the inner membrane (IM) the intermembrane space (IMS) and
the outer membrane (OM). The inner membrane forms characteristic
invaginations called cristae, which form an additional speciﬁc.
an open access article underenvironment since they are separated from the inner boundary
membrane by cristae junctions. Each different biosynthetic pathway
can be assigned to a speciﬁc compartment, but the challenge is to dissect
the communication and maintenance of the individual compartments.
Part of this maintenance is to ensure proteostasis (folding, unfolding
and degradation) to generate a homeostasis of the functional proteome
and to clear mistargeted and damaged proteins. Every sub-
mitochondrial compartment needs to control its redox milieu, which
is interestingly highly different. The inner membrane separates the re-
ducing matrix from the more oxidizing IMS [13]. For a long period of
time, researchers focused on investigating the import pathways of the
hundreds of nuclear encoded mitochondrial proteins. This culminated
in the discovery of the major pathways that translocate proteins
through the dedicated translocon complexes of the outer membrane
(TOM), the inner membrane (TIM), as well as the MIA (Mitochondrial
intermembrane space Import and Assembly) pathway, for the proteins
that are targeted to the intermembrane space [14–17]. One of the big
challenges of future research will be to investigate how the organelle
communicateswith the cytosol and the nucleus. The IMSwith its specif-
ic redox environment and the ‘controlled leakiness’ of the outer mem-
brane due to the presence of porins that allow the free diffusion of
molecules less than 5 kDa, might harbour candidates which mediate
the communication from signalling occurring inside the mitochondria
towards other organelles, the cytosol and the nucleus. Of particular in-
terest in this respect are newly identiﬁed IMS-resident proteins of
known and unknown function and proteins with at least a dualthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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with the intension to classify necessarily their function as unknown
but paying tribute to the fact that they have been assigned to the inter-
membrane space of mitochondria only recently. Such proteins could
lead us to investigate new routes in mitochondrial research. In this
review we aim to investigate new identiﬁed orphan proteins that are
either soluble in the IMS or associated with the inner membrane and
have a functional domain in the IMS. We interpret their features to
address the possible pathways they might be involved in. This perspec-
tive will be complemented by an analysis of how signalling via metabo-
lites and epigenetic modiﬁcation may contribute to the intercellular
cross-talk.
2. Mitochondrial import
Mitochondrial import has been studied extensively over the last de-
cades [14,18–26]. There is still potential to unravel new pathways in ad-
dition to the well-established import routes. Protein import normally
startswith binding of chaperones to the precursor located in the cytosol,
followed by binding to import receptors located at the outer mitochon-
drial membrane. The precursors then pass through the TOM complex,
which, in yeast, is made up by the proteins Tom20, 22, 70, the pore
forming Tom40 protein and small components named Tom 5, 6, and 7.
The precursor is subsequently guided via the TIM receptors Tim50 and
Tim23 and engages the TIM pore which is formed by the Tim17 and
23 proteins. The import process of matrix proteins is driven to comple-
tion by an ATP consuming step, which involves Tim44, mitochondrial
Hsp70 and the nucleotide exchange factor GrpE (Mge1). If a targeting
signal is present, this is cleaved by an internal protease, which subse-
quently allows the refolding of the protein [21,27]. The sorting and as-
sembly (SAM) pathway for outer membrane proteins as well as the
second TIM pathway and the MIA dependent import into the IMS are
distinct translocons that allow a compartment-speciﬁc localisation of
nuclear encoded proteins.
3. Import into the IMS
Here, we focus on twomain pathways for import into the IMSwhich
have beenwell characterised. Theﬁrst class of proteins follows the same
import route as matrix proteins but a hydrophobic so called “stop-
transfer” sequence causes an arrest of the precursor within the TIM23
complex, cleavage of the N-terminal presequence peptide by thematrix
peptidase MPP, followed by a second proteolytic cleavage of the stop-
transfer sequence in the IMS and release of the mature protein into
this compartment [28]. Different peptidases are known to participate
in this second cleavage event depending on the substrate protein, e.g.
cytochrome b2 and Mgm1 are cleaved by Imp1 and Pcp1, respectively.
A second class of IMS proteins are the ones that acquire disulﬁde
bonds during their biogenesis. A dedicated machinery oxidizes these
proteins as part of their import process into the IMS [29–33]. As men-
tioned earlier, the redox status of the IMS is oxidizing and is required
for this pathway. It is likely that the IMS ofmitochondria hasmaintained
the oxidizing environment of its corresponding bacterial compartment,
the periplasm, during the endosymbiotic process. The redox potential of
the intermembrane space is around−225mV, which is more oxidizing
than that of the cytosol at −290 mV [13]. However, Kojer and co-
workers [34]suggested (using a new generation of roGFP-based
redox-sensors) that the levels of GSH aremaintained in the IMS through
a porin-mediated diffusion from the cytosol. The identiﬁcation of the
enzymes, Mia40 [30] and Erv1, which perform regulated transfer of di-
sulﬁde bonds to substrate proteins, was a substantial advance for the in-
termembrane space oxidative pathway [35].
The mechanism for protein import into the mitochondrial inter-
membrane space starts with the reduced and, therefore, disulﬁde
bond free substrates entering via the OM. Disulﬁde bonds are intro-
duced by Mia40, and electrons are transferred from Mia40, to oxidizedErv1, and ﬁnally to oxygen produced by the respiratory chain via cyto-
chrome c and complex IV [36]. The ﬁnal electron acceptor under anaer-
obic conditions remains elusive. The introduction of a disulﬁde bond
increases the tertiary structure of the substrate and therefore traps the
protein in the IMS.
The targeting sequence for this class of proteins is called Intermem-
brane space Targeting Signal (ITS) or mitochondrial IMS-sorting signal
(MISS) and is found additionally to the CXnC cysteine motifs (e.g. the
CX9C motif in yCox17) [37,38]. The ITS is characterised by some key
properties: (i) it can function upstream or downstream of the cysteine
which interacts with Mia40, also called the docking cysteine; (ii) it is
sufﬁcient for crossing the outer membrane and even for targeting non
mitochondrial proteins; (iii) it forms an amphipathic helix with hydro-
phobic residues facing the side of the docking cysteine and dispensable
charged residues on the other side and (iv) its ﬁt is complementary to
the substrate cleft of Mia40 via hydrophobic interactions [39].
4. Proteome of the IMS
The complexity of the proteome supersedes that of the genome, due
to alternative splicing events and post-translational modiﬁcations, such
as phosphorylation or methylation. Here, we want to focus on the re-
cently undertaken approaches to investigate the proteome of the
smallest sub compartment of mitochondria, the intermembrane space.
The intermembrane space proteome requires careful analysis since the
last decades of research have pointed out the importance of this sub
compartment in processes such as (i) protein transport, (ii) lipid trans-
port, (iii) regulation and assembly of the respiratory chain, (iv) regula-
tion of redox processes, (v) coordination of apoptosis and (vi) metal
homeostasis. It is under investigation to unravel the so far unknown
pathways the IMS proteome might be involved in [40]. The investiga-
tion of the IMS holds potential to unravel players which are involved
in cysteine oxidation due to its oxidizing environment, unlike the pre-
vention of cysteinereduction in other cell compartments like the cytosol
[41]. It is also tempting to speculate about the presence of a very tightly
regulated redox sensing mechanism which will help to adjust the me-
tabolism to a given stressor. In cases of stress, induced from a variety
of sources including chemicals, metals, or particular diseases, the cell
needs to make the decision whether to undergo programmed cell
death or repair. In the case of apoptosis, it is widely recognised that
the IMS releases part of its proteome [42]. The molecules which might
eventually be targeted to the IMS only under speciﬁc stress conditions
have not yet been investigated in detail. Previous studies could identify
and verify the localisation of 31 IMS proteins in yeast [43] and 23 IMS
proteins in human mitochondria [44]. More recent investigations have
been able to detect a number of new IMS orphans in both organisms.
More speciﬁcally, these efforts were performed using the established
yeast model system S. cerevisiae [43] and, more recently, human cells.
Hung and co-workers were able to extend the current human IMS pro-
teome to a protein count of 127 [45].
5. New identiﬁed orphans of the IMS
Themain challenge in proteomics is to achieve high purity of subcel-
lular regions without contaminations from distinct organelles. This is
not a trivial task, as contact sites between organelles are frequently
part of their normal function and separating them in homogeneous
and pure fractions is very difﬁcult. Since this technical challenge limits
our understanding of pathways and mechanisms in living cells, re-
searchers have devoted substantial efforts to alleviate this problem. In
the recent literature, two attempts have been reported to create a full
inventory of the IMS proteome. Vögtle et al. induced BAX mediated re-
lease of the IMS proteome to map all IMS located candidates in
S. cerevisiae cells [43]. More recently, another group developed a very
intriguing method, where they used an engineered ascorbate peroxi-
dase (APEX), which was genetically targeted to the IMS. Upon addition
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surrounding endogenous proteins with the biotin-phenoxyl radical
oxidation product. Cells can be lysed and biotinylated proteins get sep-
arated using streptavidin beads andmass spectrometry follows for pro-
tein identiﬁcation. In combination with a stable isotope labeling by
amino acids in cell culture (SILAC)-based ratiometric tagging strategy,
allowed these authors a very accurate and extensive insight into the
IMS proteome from HEK293T cells. In this study, the putative outer
membrane proteome and new orphans established as real IMS proteins
were reported [45]. Here, we investigated reported orphans from both
studies. We believe that analysing the whole set of new identiﬁed IMS
candidate proteins will allow to cluster them in different pathways
and therefore design new strategies on how mitochondrial research
could be focussing in the future. The detailed features of these newly
identiﬁed IMS proteins (37 in human and 20 in yeast) is compiled in
Table 1. These proteins are listed as new IMS proteins despite the fact
that some have been reported to localize in mitochondria before, but
not speciﬁcally in the IMS. Also, proteins which are strongly associated
or even inserted into the inner membrane but display their function in
the IMS compartment are considered as IMS protein in this review.
The table displays databank entry, gene name, protein name, as well
asmitochondrial localisation prediction and presence of cysteinemotifs
(used databases are mentioned in detail in Table 1).
Based on experimental evidence and text-mining of available litera-
ture, we were able to assign some of the candidates into speciﬁc sub-
groups which will be discussed in the following chapters.
6. Recently discovered orphans tested for stop transfer IMS import
As mentioned earlier, some intermembrane space precursors har-
bour sequences that function as putative stop-transfer domains to arrest
translocation of proteins during import and target the precursor to the
intermembrane space. yPtc5 (YOR090C), a mitochondrial type 2C pro-
tein phosphatase, is plausibly presented from Vögtle et al. to follow
the presequence pathway and subsequently be processed by an inner
membrane protease in order to be ﬁnally released to the IMS [43]. Pre-
viously, this protein was suggested to be involved in the regulation of
the pyruvate dehydrogenase complex by dephosphorylating the serine
133 of the yPda1p subunit [46]. This complex is located in themitochon-
drial matrix, whereas the branched-chain α-ketoacid dehydrogenase
complex (BCKDC) which is cross reacting with PDH complex proteins,
is located on the inner mitochondrial membrane. As now the protein
has been convincingly located in the IMS, an interactionwith a complex
in the inner membrane seems more likely. A deﬁciency in enzymes of
the BCKDC complex or its inhibition lead to accumulation of
branched-chain amino acid and their derivatives, called ketone bodies.
Ketone bodies cause a sweet smell to bodily excretions and lead to a pa-
thology known as maple syrup disease. Assigning yPtc5 to the IMS pro-
vides the opportunity to investigate if the BCKDC complex might be
regulated via yPtc5 mediated dephosphorylation and thus opens new
perspectives in maple syrup disease research.
7. Recently discovered orphans tested for MIA40-dependent import
MIA-dependent precursors typically contain twin CX9C or CX3Cmo-
tifs [39]. In the list of new identiﬁed orphans, only two of the proteins
display this characteristic, yPet191 and yCmc2. Interestingly, yPet191
carries the typical cysteine motif but seems to be imported indepen-
dently from the MIA pathway [47]. However, other proteins with un-
common cysteine motifs (see Table 1) could be identiﬁed, including
yCox12, Ymr244c-a (yCoa6), yNce103 and Ybl107c (yMix23). The re-
sults from Vögtle and co-workers demonstrate that the proteins with
uncommon cysteine motifs, except yNce103, require the MIA import
machinery [43]. The yNce103 protein was not further investigated.
Furthermore, another set of MIA-dependent precursors, which do not
require their cysteine motifs in order to become imported into themitochondria, has also been identiﬁed. This group includes the yeast
proteins yAtp23 [48], yTim22 [49], yMrp10 [50] and the human protein
CHCHD3 [51]. Therefore, every newly discovered orphan could also be a
MIA substrate, although this would need to be tested experimentally.
Another important aspect concerns quality control systems of newly
imported IMS proteins. Therefore, the identiﬁcation of prolyl 4-
hydroxylase (hP4HB), a multifunctional enzyme that belongs to the
protein disulﬁde isomerase family, might be a ﬁrst indication of the
presence of such a control system in the IMS. This enzyme also displays
disulﬁde isomerase activity. Based on the presence of two thioredoxin
domains which can catalyze the formation, breakage and rearrange-
ment of disulﬁde bonds, this protein might play a role in overcoming
the aggregation of misfolded proteins [52].
8. IMS candidates involved in mitochondrial respiration
Ymr244c (yCoa6) is a protein involved in cytochrome c oxidase
(Complex IV) assembly and achieves the delivery of copper to Complex
IV reaching the complex from the IMS [43,53]. yCoa6 is also required for
efﬁcient formation of respiratory supercomplexes comprised of Com-
plexes III and IV [43]. Its transcription is induced in response to speciﬁc
DNA-damaging agents and the protein abundance increases in response
to DNA replication stress [54,55]. Taken together, the data suggest that
this protein may be involved in stress response and respiration. The de-
tection of human Coa7b, a complex IV assembly factor is therefore not
surprising. Detection of yQcr6 (subunit 6 of the ubiquinol cytochrome-
c reductase complex) in the IMS seemed to be less unexpected. This
subunit is discussed by Schmitt et al., Yang et al., and Brandt [56–58].
This highly acidic protein is required for maturation of cytochrome c1
and might be loosely associated with the complex since it is easily
released into the intermembrane space according to these studies
and would therefore account for its detection in the IMS. yPet191
characterised byMcEwen, et al., is described as essential for cytochrome
c oxidase maturation in recent literature [47,59]. yCox11 is anchored to
the mitochondrial inner membrane by a single transmembrane seg-
ment, whereas its C terminus contains a copper-binding domain, is ex-
posed to the intermembrane space and forms a homodimer that binds
two Cu(I) ions. Copper is delivered to yCox11 by yCox17 [60]. Also, sub-
unit VIb of human complex IV (Cox12 in yeast) is described as only
loosely attached to the respiratory complex IV and allows detection of
this subunit without surprise in the IMS [61].
The Saccharomyces cerevisiae RIB4 gene codes for 6,7-dimethyl-8-
ribityllumazine synthase involved in riboﬂavin biosynthesis [62]. Vögtle
et al. discuss it as a putative candidate required for respiration similar to
its homolog yRIB3 [43,63].
Aras and co-workers suggested the renaming of the hCHCHD2
(AAG10, C7orf17) protein asmitochondria nuclear retrograde regulator
1 (hMNRR1) [64]. They conﬁrm the IMS localisation and its import as
being Mia40 dependent. Its presence and association with complex IV
in the IMS is required for COX activity. Upon stress, hMNRR1 localizes
to the nucleus and acts as transcription factor. One of its targets is the
hCOX4-2 gene, whose transcription is stimulated in hypoxic conditions.
The reported interactome of the hCHCHD2 protein displays candidates
such as hCOX5B, a cytochrome c oxidase subunit, hSIRT1 and hHTT
(Huntington disease protein homolog). hSIRT1 was shown to de-
acetylate and affect the activity of both members of the PGC1-alpha/
ERR-alpha complex, which are essential metabolic regulatory transcrip-
tion factors and are known to regulate expression of respiratory chain
complex subunits. Complex IV is the most affected respiratory chain
complex in Huntington's disease. Taking these facts together, it is
tempting to ask the question if hCHCHD2 takes part in the communica-
tion path between respiratory chain assembly and PGC1-mediated
signalling. Interestingly, Liu et al. discuss hCHCHD2 as one of the nega-
tive regulators of mitochondria-mediated apoptosis with no known ho-
mology to the Bcl-2 family, while Singleton detected mutations in the
hCHCHD2 gene of late onset Parkinson patients [65,66]. Furthermore,
Table 1
Summary of the newly identiﬁed proteinmembers of the intermembrane space proteome. Assignment of gene names and accession numberswas achieved by following annotations fromUniProt/SGD. Cell compartment annotation as summarized in
the table is based on evidence found in speciﬁc literature. The “Yeast/Human homolog” column refers to the homologous yeast proteins in the case of the human proteome and the homologous human proteins in the case of the yeast proteome. The
“Mitochondrial/IMS localisation veriﬁed” column refers to the proteins that have been veriﬁed experimentally (western blotting orﬂuorescencemicroscopy) to have amitochondrial localisation for the humanproteome or an IMS speciﬁc localisation
for the yeast proteome. (* Laminin contains a very large number of both typical (eg. CX9C) and non-typical (eg. CX5C) cysteine motifs).
UniProt
accession
number
Protein names Gene names Yeast/ human
homolog
Molecular
weight (kDa)
CXnC motif Previous
cell compartment
annotation
Mitochondrial/
IMS localisation
veriﬁed?
Human proteome
Q9NUJ1 Mycophenolic acid acyl-glucuronide esterase, mitochondrial ABHD10 – 33.9 CX6C, CX9C – No
Q9NPH0 Lysophosphatidic acid phosphatase type 6 ACP6 – 48.9 CX7C, CX4C Mitochondria [1] No
Q53H12 Acylglycerol kinase, mitochondrial AGK, MULK – 47.1 CX13CX8C, CX5C Mitochondrial membrane [2] No
Q9BUR5 MICOS complex subunit MIC26 APOO,
MIC23, MIC26
– 22.3 CX6C ER/Golgi, inner
mitochondrial membrane [3]
Yes [4]
Q96BQ5 Coiled-coil domain-containing protein 127 CCDC127 – 30.8 – – Yes [4]
Q4VC31 Coiled-coil domain-containing protein 58 CCDC58 – 16.6 – – No
Q4G0I0 Protein CCSMST1 CCSMST1 – 15.0 CX8C – No
P30307 M-phase inducer phosphatase 3 CDC25C – 53.4 CX6CX16C, CX7C, CX10CXC,
CX5CX13C
Nucleus [5] Yes [4]
A8MTT3 Protein CEBPZOS CEBPZOS – 9.3 – – Yes [4]
Q9H078-2 Caseinolytic peptidase B protein homolog CLPB, HSP78, SKD3 – 75.4 CX9C Mitochondria [6] No
Q9NRP2 COX assembly mitochondrial protein 2 homolog CMC2, C16orf61 CMC2 9.5 Twin CX9C Inner membrane facing IMS
[7]
No
Q5JTJ3-2 Cytochrome c oxidase assembly factor 6 homolog COA6, C1orf31 COA6 14.1 CX12C, CX9CX10CX11C – Yes [8]
Q96BR5 Cytochrome c oxidase assembly factor 7 COA7, RESA1 – 25.7 CX3CX8C, CX8C, CX4CX10C,
CX7C, CX6CX7C
– Yes [4,9]
Q9P0S2 Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial COX16, C14orf112 COX16 12.3 – Mitochondrial membrane
[10]
No
Q5RI15 Cytochrome c oxidase protein 20 homolog COX20, FAM36A COX20 13.3 CX13CX3C – No
P36957 Dihydrolipoyllysine-residue succinyltransferase component of
2-oxoglutarate dehydrogenase complex, mitochondrial
DLST, DLTS KGD2 48.8 CX16CX12C – No
E7EQY1 Protein FAM136A FAM136A – 26.8 CX9C, CX3CC, triple CX3C – No
Q96A26 Protein FAM162A FAM162A, C3orf28 – 17.3 CX3C – No
Q96AY3 Peptidyl-prolyl cis-trans isomerase FKBP10 FKBP10 FPR2 64.2 CX15C – Yes [4]
Q9NRV9 Heme-binding protein 1 HEBP1, HBP – 21.1 – Cytosol [11] No
P11047 Laminin subunit gamma-1 LAMC1 – 177.6 CXnC* – No
O14880 Microsomal glutathione S-transferase 3 MGST3 – 16.5 – – Yes [4]
Q9Y6H1 Coiled-coil-helix-coiled-coil-helix domain-containing protein 2,
mitochondrial; Aging-associated gene 10 protein
MNRR1, CHCHD2,
AAG10, C7orf17
MIX17 15.5 CX9CX9CX9C Nucleus [12], mitochondria
[13]
No
Q14596 Next to BRCA1 gene 1 protein NBR1 – 107.4 CX2CX10CX2CX5CX2C Cytosol [14] Yes [4]
P80303 Nucleobindin-2 NUCB2,
NEFA
– 50.2 CX5C Golgi apparatus [15] No
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Q9NX40 OCIA domain-containing protein 1, Ovarian carcinoma immunoreactive
antigen
OCIAD1, OCIA – 27.6 CX14C – No
P07237 Protein disulﬁde-isomerase P4HB PDI1 57.1 Twin CX2C ER [16,17] No
Q9H7Z7 Prostaglandin E synthase 2 PGES2, C9orf15 – 41.9 CX2C Golgi apparatus membrane
[18]
No
P30048 Thioredoxin-dependent peroxide reductase, mitochondrial PRDX3, AOP1 TSA1 27.7 CX9CX14C – Yes [19]
Q13162 Peroxiredoxin-4 PRDX4 TSA1 30.5 – Cytosol [20] No
Q14257 Reticulocalbin-2 RCN2, ERC55 – 36.9 – – No
Q96DB5 Regulator of microtubule dynamics protein 1 RMDN1, FAM82B – 35.8 CX2C – No
Q96JX3 Protein SERAC1 SERAC1 – 74.1 CX2CC, CX13C, CX9C Mitochondria-ER interface
[21]
No
O95721 Synaptosomal-associated protein 29 SNAP29 – 29.0 – Cytosol [22] No
Q9NQZ5 StAR-related lipid transfer protein 7, mitochondrial STARD7, GTT1 – 43.1 – – No
P56962 Syntaxin-17 STX17 – 33.4 CX10C ER, ERGIC
[23]
Yes [4]
O95881 Thioredoxin domain-containing protein 12, ERp18 TXNDC12 – 19.2 CX2C ER [24] No
Yeast proteome
Q3E846 Cytochrome c oxidase assembly factor 6 COA6 (YMR244C-A) COA6 12.4 CX9C, CX10C – Yes [8,25]
P19516 Cytochrome c oxidase assembly protein COX11, mitochondrial COX11 (YPL132W) COX11 34.0 CXC Mitochondrial membrane
[26]
No
Q01519 Subunit VIB of cytochrome c oxidase COX12 (YLR038C) COX6B2 9.8 CX9C, CX10C Integral to IM [27] Yes [25]
P14832 Cytoplasmic peptidyl-prolyl cis-trans isomerase CPR1 (YDR155C) PPIF 17.4 – Cytosol [28] Yes [25]
P00950 Tetrameric phosphoglycerate mutase GPM1 (YKL152C) PGAM2 27.6 – Cytosol, extracellular [29] Yes [25]
P40037 Homologous Mmf1p Factor , member of the p14.5 protein family HMF1 (YER057C) – 13.9 – Cytosol [30] Yes [25]
P40581 Peroxiredoxin HYR1 HYR1 (YIR037W) – 18.6 – Cytosol [31] Yes [25]
P38162 Mitochondrial intermembrane space cysteine motif-containing protein
MIX23
MIX23 (YBL107C) – 23.0 CX14C, CX13C – Yes [25]
P40364 Mitochondrial peculiar membrane protein 1 MPM1 (YJL066C) – 28.5 – Mitochondrial membrane
[32]
Yes [25]
P14908 Mitochondrial transcription factor 1 MTF1 (YMR228W) – 39.7 – Mitochondria [33,34] No
P53615 Carbonic anhydrase NCE103 (YNL036W) – 24.9 CX8C,
CX16CX8CX4CX5CX12C
– Yes [25]
P38075 Pyridoxine phosphate oxidase PDX3 (YBR035C) PNPO 26.9 – – No
Q02772 Protein required for assembly of cytochrome c oxidase PET191 (YJR034W) – 12.4 Twin CX9C Integral to IM facing the IMS
[35]
Yes [25]
P27796 3-ketoacyl-CoA thiolase POT1
(YIL160C)
ACAA1 44.7 CX16C Peroxisome [36] No
Q12511 Mitochondrial type 2C protein phosphatase PTC5 (YOR090C) PDP1 63.7 – – Yes [25]
P00127 Cytochrome b-c1 complex subunit 6 QCR6 (YFR033C) – 17.3 – Mitochondrial membrane
[37,38]
Yes [25]
P50861 Lumazine synthase RIB4
(YOL143C)
– 18.6 – – Yes [25]
P29509 Cytoplasmic thioredoxin reductase TRR1 (YDR353W) – 34.2 CX2C Cytosol [39] Yes [25]
P22217 Cytoplasmic thioredoxin TRX1 (YLR043C) TXN 11.2 CX2C Cytosol [39] Yes [25]
P38081 Putative glycoside hydrolase of the mitochondrial intermembrane space YBR056W – 57.8 – – No
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2618 E. Nuebel et al. / Biochimica et Biophysica Acta 1863 (2016) 2613–2623Wei and co-authors expand the role of this protein towards cell migra-
tion regulation and cancer [67]. This protein is therefore one of the can-
didates which supports the underestimated role of the IMS proteome as
being involved in a complex communication system within the cell.
9. IMS candidates in redox homeostasis
The thioredoxin system together with the glutathione/glutaredoxin
systemhelp tomaintain the reduced cell environment and play a signif-
icant role in defending the cell against oxidative stress. The yeast cyto-
plasmic thioredoxin system is comprised of the thioredoxins yTrx1
and yTrx2 and the thioredoxin reductase yTrr1. The mitochondrial ma-
trix thioredoxin system, on the other hand, is composed of thioredoxin
yTrx3 and the thioredoxin reductase yTrr2 [68]. It is speculated that the
cytoplasmic thioredoxin systemmayhave an overlapping functionwith
the glutathione/glutaredoxin system, but themitochondrial thioredoxin
system does not appear to be able to substitute for either the cytoplas-
mic thioredoxin or glutathione/glutaredoxin systems [69,70]. It seems
more likely that the mitochondrial thioredoxin proteins are implicated
in oxidative stress defense generated during respiratory metabolism
[71]. Assigning the previously only cytosolic proteins yTrr1 and yTrx1
to the IMS will open up the chance to unravel the speculated overlap
of the systems or a possible communication path between the two sys-
tems. Recentwork by Greetham et al. shows evidence that under oxida-
tive stress the redox state of amitochondrial thioredoxin regulates yeast
apoptosis. This ﬁnding connects the thioredoxin system with a signal-
ling pathway, which mediates antioxidant defense and cell death at
the same time [72].
Support for a redox maintenance system in the IMS is the discovery
of Endoplasmic reticulum resident protein 18 (hERp18) in the human
IMS orphan data set. This protein belongs to the thioredoxin superfam-
ily, which catalyzes disulﬁde bond formation and isomerization. This
protein is discussed to play a role in the defense against endoplasmic
reticulum stress. Equally, it may maintain this function in the IMS [73].
Another candidate for a stress defense mechanism is microsomal gluta-
thione S-transferase 3, also found for the ﬁrst time in mitochondria.
MGST3 has been found to have LTC4 (leukotriene-C4) synthase activity
and is able to reduce 5-HPETE ((S)-5-hydroperoxy-8,11,14-cis-6-
trans-eicosatetraenoic acid) through the utilisation of GSH [74].
yHyr1 (also known as Gpx3 or Orp1) is a thiol peroxidase which
functions as a hydroperoxide receptor to sense intracellular hydroper-
oxide levels and transduce a redox signal to the yYap1 transcription fac-
tor. yHyr1 interacts with the C-terminus of yYap1 via a disulﬁde bond.
Nuclear export of yYap1 is inhibited, resulting in activated yYap1 tran-
scription [75]. The Hyr1-dependent activation of yYap1 is also depen-
dent on the protein yYbp1 [76]. Localisation of a transcription factor
interacting protein to the IMSmight allowus to investigatemechanisms
which regulate transcription after receiving a mitochondrial signal.
The proteins encoded by the hPRDX3 and hPRDX4 genes are antiox-
idant enzymes belonging to the peroxiredoxin family. The hPRDX4 pro-
tein was localized to the cytoplasm. Peroxidases of the peroxiredoxin
family reduce hydrogen peroxide and alkyl hydroperoxides to water
and alcohol with participation of reducing equivalents derived from
thiol-containing donor molecules. The presence of these proteins in a
subcellular compartment with a more oxidative milieu points towards
a speciﬁc function of the IMS in thepathwayof oxidative stress response
andmake both proteins highly interesting candidates to investigate ox-
idative stress signalling [77,78].
10. IMS candidates for apoptosis signalling
yHmf1 is a member of the p14.5 protein family and is heat shock in-
ducible. It was shown to functionally complement yMmf1 when
targeted to mitochondria. Oxelmark et al. identiﬁed yMmf1 as a novel
yeast mitochondrial protein involved in maintenance of the mitochon-
drial genome, whereas members of the 14.5 protein family are ofteninvolved in apoptotic pathways [79]. Therefore, it might be interesting
to investigate yHmf1's speciﬁc function and the connection of mito-
chondrial genome maintenance in context of apoptosis signalling.
hFAM162A (C3orf28) is proposed to be involved in regulation of
apoptosis. The exact mechanism may differ between cell types/tissues.
hFAM162A is speculated to be involved in hypoxia-induced cell death
with cytochrome c release and caspase activation and inducing mito-
chondrial permeability transition. In neuronal cells, hFAM162A might
promote release of hAIFM1 frommitochondria to the cytoplasm follow-
ed by its translocation to the nucleus; however, the involvement of
caspases has been debated upon in the literature [80,81]. The protein in-
teracts with hHSP90AB,which is essential for hFAM162Amitochondrial
localization and pro-apoptotic activity. The reported interaction with
hVDAC2 explains the link in inducing the mitochondrial permeability
transition.
11. IMS candidates for lipid signalling
An interconnected and truly complex signalling network which
modulates a variety of cell events is regulated by production versus
elimination of signalling lipids such as e.g. phosphatidic acid (PA), diac-
ylglycerol (DAG), and phosphatidylinositol 4,5-bisphosphate (PI4,5P2).
PA can be generated by hydrolysis of cardiolipin mediated by e.g. a
newly identiﬁed, non-canonical member of the PLD superfamily
named MitoPLD, which localizes to the mitochondrial surface and par-
ticipates in mitochondrial fusion. In addition, PA on the mitochondrial
surface may also trigger a signalling cascade that elevates DAG, leading
to downstream events that affect mitochondrial ﬁssion and energy pro-
duction ormay stimulate local production of PI4,5P2 to facilitate subcel-
lular trafﬁcking or Ca2+ inﬂux [82]. Identiﬁcation of proteins involved in
lipidmetabolism, not only at themitochondrial envelope but also in the
IMS, might therefore unravel necessary links tomediate signalling from
the surface to thematrix or vice versa. In this context, further investiga-
tion will be required as to why enzymes of the beta-oxidation machin-
ery are needed in the IMS.
One of these candidate proteins is yPot1, which is also known to be
present in peroxisomes. yPot1, a 3-ketoacyl-CoA thiolase with broad
chain length speciﬁcity, cleaves 3-ketoacyl-CoA into acyl-CoA and
acetyl-CoA during beta-oxidation of fatty acids.
yPdx3 pyridoxine (pyridoxamine) phosphate oxidase, instead, is re-
ported from Loubbardi et al. to be involved in sterol uptake, with the
mutant yeast strain displaying atypical fatty acid, sterol, and cyto-
chrome patterns [83]. Detecting components of lipid metabolism regu-
lation in the IMS contributes either to the general homeostasis of this
sub-compartment or harbours the potential to investigate new routes
of lipid signalling.
The transport of phospholipids to mitochondrial membranes re-
mains unclear, except for the fact that the endoplasmic reticulum (ER)
contact sites might be involved [84]. In this context, it is important to
note that the component of the MICOS complex hMIC26 was detected
in the human set of IMS orphans. This protein is not only involved in
cristae formation by modulating cristae junctions but has also been re-
ported to play a role in lipid transport [85,86]. Furthermore, the trafﬁc
of phospholipids between the mitochondrial membranes is far from
being understood. Recently, Connerth et al. were able to identify
yUps1 as phosphatic acid shuttle protein, residing in the IMS [87].
hACP6 protein, one of the recent orphans, hydrolyses lysophosphatidic
acid (LPA), containing a medium length fatty acid chain to the corre-
sponding monoacylglycerol. Hiroyama and Takenawa propose involve-
ment of ACP6 in mitochondrial lipid biosynthesis regulation [88]. Also,
hGTT1, a mitochondrial StAR-related lipid transfer protein 7 with the
ability to transfer phophatidylcholine [89], extends the list of IMS pro-
teins involved in lipid signalling. hSERAC1 (serin active site containing)
is a phosphatidylglycerol remodeling protein that has so far been found
at the interface between the mitochondria and the ER, where it medi-
ates phospholipid exchange. The encoded protein plays a major role in
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in this gene are a cause of 3-methylglutaconic aciduria with deafness,
encephalopathy, and Leigh-like syndrome (MEGDEL) [90]. Therefore,
the assignment of this protein to the IMS might highlight a regulatory
cycle of controlled phospholipid exchange. The protein encoded by
the hAGK gene is a mitochondrial membrane protein involved in lipid
and glycerolipid metabolism. The lipid kinase catalyzes the formation
of phosphatidic and lysophosphatidic acids. Defects in this gene have
been associated with mitochondrial DNA depletion syndrome 10 [91].
To summarize, the assignment of candidates being involved in lipidme-
tabolism highlight the need to investigate to what extent the IMS con-
tributes to lipid signalling pathways.
12. IMS candidates for calcium homeostasis, Alzheimer's disease
and beyond
Orphans which add even more diversity to pathways, but have not
been investigated in detail in the context of mitochondrial research
are discussed below.
The discovery of two different SNAREproteins hSTX17 and hSNAP29
are a surprise but, in the context of mitophagy processes, they are im-
portant to consider.
yMtf1 is a mitochondrial RNA polymerase speciﬁcity factor [92]
displaying structural similarity to S-adenosylmethionine-dependent
methyltransferases. yMtf1 interacts with the Rpo41-promoter complex
and stabilizes the complex, thusenhancing DNA bending andmelting to
facilitate the pre-initiation open complex formation. This particular pro-
teinwas also found to be required for promoter speciﬁc activity through
the suppression of Rpo1 non-speciﬁc transcription. [93]. The yMpm1
protein is an intermembrane space protein with unknown function.
Therefore, interpretation of its reported interactome revealed interac-
tion with a group of proteins involved in cristae formation and mem-
brane organisation such as yMic10, yMic12, yMic60 and yMdm10.
More exciting is the evidence for interaction of yMpm1 with yMpc1, a
highly conserved subunit of the mitochondrial pyruvate carrier. This
carrier is located in the mitochondrial inner membrane and is com-
prised of yMpc1 and yMpc2 or yMpc3. Mutations in yMpc1 deplete py-
ruvate uptake in mitochondria [94]. The assignment of yMpm1 to the
IMS putatively interacting with the pyruvate carrier of the inner mem-
brane might be interesting to explore, since regulation of the pyruvate
carrier is far from understood but harbours potential for cancer therapy
[95].
IMS candidates with dual localisation which are candidates for fur-
ther investigation can be found in Table 1, with its listing of localisation
to other cell compartments. Less interesting candidates are yGpm1,
which is involved in glycolysis, and Ybr056w, a putative glycoside hy-
drolase of themitochondrial intermembrane space. A yNCE103 deletion
was reported by Götz et al., producing an oxygen sensitive phenotype
with reduced growth under aerobic conditions [96].
The association of a prostaglandin E synthase named hPTGES2
(C9orf15) with the IMS raises interest at a second glance when discov-
ering the reported literature [97], which speculates a function for this
IMS protein in replacing the cytosolic PGES in later stages of Alzheimer's
disease.
The full-length protein encoded by the hHEBP1 gene is an intracellu-
lar tetrapyrrole-binding protein. This protein includes a natural
chemoattractant peptide of 21 amino acids at the N-terminus, which
is a natural ligand for formyl peptide receptor-like receptor 2 (FPRL2)
and promotes calcium mobilization and chemotaxis in monocytes and
dendritic cells. A fair question to be asked would be if this protein par-
ticipates in calcium regulation in the IMS. Another orphan putatively in-
volved in calcium signalling is hPPIF, the human homolog of yCpr1. In a
study usingmice as a model system, the importance of this protein and
its involvement in the permeability transition pore, thereby regulating
calcium levels, are investigated [98]. Regulation of Ca2+ levels in mito-
chondria is a critically important task. The involvement of the IMS inthis particular process is under investigation and gains further support
from the discovery of two proteins which might be involved: Calcium-
binding protein hERC-55 [99] and hNEFA [100]. hERC-55 even offers
the possibility to be a player in the redox defense pathways, since it is
shown to interact with peroxiredoxin-6, too. Therefore, it becomes a
highly interesting candidate to investigate.
13. Cross-talk mediated frommetabolites and epigenetics
One of the exciting questions of recent research is how metabolism
integrates with epigenetic and genetic programs to regulate cell
function and especially pluripotent stem cell (PSC) fate and function.
The regulation of metabolite ﬂuxes is achieved by transcription factors
including c-Myc and HIF1α and signalling molecules such as PI3K,
AKT, and mTOR [101]. Studies in mammalian cells have shown that
metabolites can function as cofactors or substrates for chromatin
structure regulating enzymes and inﬂuence gene expression. The role
of mitochondria, hosting several biosynthetic pathways and being a
source of signalling ROS, will be important to dissect in the future.
Especially in the ﬁeld of stem cell research, the understanding of the
role of mitochondria in the context of metabolite and signalling cross-
talk will prove to be very exciting. Acetyl-CoA generated in diverse
pathways of glucose, fatty acid, or amino acid catabolism in mitochon-
dria can be transported to the cytosol and be targeted to the nucleus
to increase histone acetylation [102,103]. Another mitochondrial me-
tabolite, α-ketoglutarate, can exit the organelle to serve as a cofactor
for dioxygenase enzymes including TET-family DNA hydroxylases,
Jumonji-family histone demethylases and, eventually, prolyl hydroxy-
lases which themselves control HIF1α/2α transcription factor stability
[104].
Candidates that are discussed to have the potential to be located in
the IMS but might be targeted there with transient localisation in the
nucleus could be relevant to explore the communication and regulation
of gene expression. The orphan yHmf1, aswell as yCpr1, are such candi-
dates. hCiapin1 (yDre2) displays features of typical IMS proteins, such
as the cysteine motif in combination with the hydrophobic stretch
[105]. Additionally, the ﬂexible C-terminus resembles amethyltransfer-
ase motif. The protein has been reported to be present in the nucleus,
[106,107] and has been found on the mitochondrial surface. Such a
localisation would be compatible with a role in translating signals
frommitochondria to the nucleus thereby inﬂuencing gene expression.
Researchwith cancer cells has shown that defects in TCA cycle enzymes,
such as succinate dehydrogenase, fumarate hydratase, and isocitrate de-
hydrogenase, cause inherited benign or malignant tumours by altering
DNA and histone modiﬁcations thereby causing transcriptional dysreg-
ulation [108].
Deacetylase enzymes, such as the Sirtuin family proteins, are sensi-
tive to the redox state of the cell compartment and can impact histone
modiﬁcations and posttranscriptional changes through non-histone
protein deacetylation [109]. Many biological processes are regulated
by metabolic activities and/or are impacted by the cellular redox state.
For example, the redox state modulates the balance between self-
renewal versus differentiation in dividing glial precursor cells [110].
The accumulation of ROS is minimized in PSCs, a feat which is achieved
by a reduction in substrate oxidation and respiratory coupling. It is still
under investigation how the transition from uncoupled to coupled res-
piration during differentiation is achieved. The detection of proteins like
hCHCHD2 (C7orf17), whichmight interact with PGC1-alpha, in the IMS,
make them attractive candidates to investigate.
Additionally, the elevated expression of antioxidant stress genes
such as yUCP2, ySOD2, and yGPX2 contribute to the lower ROS level.
The assignment of yHyr1 to the yeast intermembrane space extends
the list of enzymes which might mediate response to ROS speciﬁcally
in the IMS. As soon as the differentiation process is induced, these
genes become repressed [111,112]. Increase of ROS promotes lineage-
speciﬁc differentiation, which in the case of cardiomyocyte precursor
Fig. 1. The IMS proteome of mitochondria is involved in several cellular processes. These include (i) epigenetic regulation in the nucleus, (ii) apoptosis signalling, (iii) regulation of
translation, (iv) lipid signalling, (v) signalling via reactive oxygen species (ROS), (vi) maintenance of redox homeostasis and (vii) regulation of metabolism and of the respiratory
transport chain (RTC).
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way [113]. In the case of cancer cells, the effect of increased ROS accu-
mulation promotes cell proliferation but not differentiation [114]. The
mechanisms for this differential response to ROS in distinct cellular con-
texts will require further investigation and are exciting complementa-
tions to mitochondrial research. During mouse Embryonic Stem Cell
(mESC) differentiation, the ratio of reduced to oxidized glutathione de-
creases aswell as the level of NADH,while the unsaturatedmetabolome
with carbon-carbon double bonds is replaced by an oxidative metabo-
lome, effectively increasing the overall cellular oxidation state [115,
116]. Yanes and coworkers demonstrated that blocking the oxidative ei-
cosanoid signalling cascade in ESCs can also delay differentiation [116].
Tight regulation of speciﬁc redox species, such as the NAD+/NADH
ratio, is critical for signalling events that require NAD+-dependent
deacetylase activities [117]. Since the NAD+/NADH ratio is regulated
by glycolytic andmitochondrial activities that change dramatically dur-
ing differentiation or reprogramming [118], the NAD+/NADH redox
state may have a role in driving PSC fate. These interesting ﬁndings
linked to stem cell research inversely stimulate the discussion of so far
underestimated regulations of the redox state in the different cell com-
partments due to their different oxidativemilieu. Investigating new IMS
orphans which might be involved in redox state homeostasis, such as
yTrx1 and yTrr1 with their dual localisation, therefore sparks new ﬁelds
for mitochondrial research.14. Future directions
Here, we have discussed the current knowledge and function of pro-
teins which were only recently assigned to the IMS. The novel orphans
were investigated with prediction tools to allow a ﬁrst indication on
which function this protein might be involved in. Also, information
from protein databases and previous literature has been interpreted to
spark speculation about future research. In this review, we have
highlighted fragmented evidence of proteins which have been newly
assigned to the IMS andhave tried to integrate this information together
with functional data and analysis of pathways that may help us to un-
ravel some of the future challenging questions on how mitochondria
have a central role in several signalling processes in the cell (depicted
schematically in Fig. 1).Based on ﬁndings related to cancer or stem cell research we can aim
to unmask the communication mechanisms between the cell organ-
elles, speciﬁcally between other compartments and mitochondria. It is
also important to note that we need to integrate the knowledge of the
metabolome, the metabolism and its regulation with the proteome
and traditional signalling pathways to broaden our understanding and
start the journey of exploring the next step in mitochondrial research.
Here, we have featured the main traditional knowledge about mito-
chondria, signalling and protein sorting and tried to incorporate the
knowledge which was discovered in cancer and stem cell science. We
have focused especially on what we can learn from the newly identiﬁed
orphans of the IMS in the context of intracellular communication. We
have found links to apoptosis, lipid, metal and redox stress signalling.
Future projectsmight focus speciﬁcally on addressing someof these sig-
nalling pathways, which are mediated by the new identiﬁed IMS
orphans, and help us to understand how mitochondria contribute to
the whole physiology of a healthy and functional cell.
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